Retatrutide
Triple-agonist GLP-1 / GIP / glucagon research peptide.
- CAS
- 2381089-83-2
- Molecular weight
- ≈ 4731 g/mol
- Form
- Lyophilised white powder, sealed vial
- Purity
- >99.0% by HPLC
- Sequence
- 39 amino acid synthetic polypeptide (LY3437943 analogue)
Free nationwide shipping over ₱7,000, otherwise flat ₱350. Sold for in-vitro laboratory research only — not for human or veterinary use.
Overview
Retatrutide is a synthetic 39-amino-acid polypeptide investigated in laboratory settings as a triple agonist at the GLP-1, GIP and glucagon receptors. It is one of the most widely studied next-generation incretin research compounds in metabolic literature.
Our Retatrutide is supplied as a lyophilised powder in a 10 mg sealed glass vial, batch-tested by HPLC and mass spectrometry for sequence identity and purity before release to the Philippine market.
Handling & storage
- Reconstitute with bacteriostatic water using slow injection down the vial wall — never shake.
- Store lyophilised vials at -20°C. Store reconstituted solution at 2-8°C.
- Avoid repeated freeze-thaw cycles which degrade peptide chains.
Research areas
Published in-vitro work characterises simultaneous agonism at GLP-1R, GIPR and GCGR, with researchers examining downstream cAMP signalling and receptor internalisation kinetics.
Frequently referenced in preclinical energy-balance, adipose signalling and glucose-handling models.
Lyophilised form demonstrates strong stability at -20°C; reconstituted solution should be kept at 2-8°C and protected from light.
Researchers also order
Growth HormoneBlended GHRH analogue and selective ghrelin-receptor agonist.
